TY - JOUR
T1 - Serotonin transporter genotype linked to adolescent substance use treatment outcome through externalizing behavior
AU - Chung, Tammy
AU - Cornelius, Jack R.
AU - Martin, Christopher S.
AU - Ferrell, Robert
AU - Maisto, Stephen A.
AU - Clark, Duncan B.
N1 - Publisher Copyright:
© 2014 Chung, Cornelius, Martin, Ferrell, Maisto and Clark.
PY - 2014/7/1
Y1 - 2014/7/1
N2 - Meta-analyses suggest that the serotonin transporter linked polymorphic region (5-HTTLPR) short (S) allele, relative to the long (L) allele, is associated with risk for alcohol dependence, particularly among individuals with early onset antisocial alcoholism. Youth in substance use treatment tend to show antisocial or externalizing behaviors, such as conduct problems, which predict worse treatment outcome. This study examined a pathway in which 5-HTTLPR genotype is associated with externalizing behavior, and the intermediate phenotype of externalizing behavior serves as a link between 5-HTTLPR genotype and substance use treatment outcome in youth. Adolescents (n = 142) who were recruited from addictions treatment were genotyped for 5-HTTLPR polymorphisms (S and L G carriers vs. L A L A ), assessed for externalizing and internalizing behaviors shortly after starting treatment, and followed over 6-months. 5-HTTLPR genotype was not associated with internalizing behaviors, and was not directly associated with 6-month substance use outcomes. However, 5-HTTLPR genotype was associated with externalizing behaviors (S and L G > L A L A ), and externalizing behaviors predicted alcohol and marijuana problem severity at 6-month follow-up. Results indicated an indirect (p < 0.05) and non-specific (i.e., both alcohol and marijuana severity) effect of 5-HTTLPR genotype on youth substance use treatment outcomes, with externalizing behaviors as an important linking factor. Adolescents in substance use treatment with low expressing (S and L G ) 5-HTTLPR alleles and externalizing behavior might benefit from intervention that addresses serotonergic functioning, externalizing behaviors, and substance use to improve outcomes.
AB - Meta-analyses suggest that the serotonin transporter linked polymorphic region (5-HTTLPR) short (S) allele, relative to the long (L) allele, is associated with risk for alcohol dependence, particularly among individuals with early onset antisocial alcoholism. Youth in substance use treatment tend to show antisocial or externalizing behaviors, such as conduct problems, which predict worse treatment outcome. This study examined a pathway in which 5-HTTLPR genotype is associated with externalizing behavior, and the intermediate phenotype of externalizing behavior serves as a link between 5-HTTLPR genotype and substance use treatment outcome in youth. Adolescents (n = 142) who were recruited from addictions treatment were genotyped for 5-HTTLPR polymorphisms (S and L G carriers vs. L A L A ), assessed for externalizing and internalizing behaviors shortly after starting treatment, and followed over 6-months. 5-HTTLPR genotype was not associated with internalizing behaviors, and was not directly associated with 6-month substance use outcomes. However, 5-HTTLPR genotype was associated with externalizing behaviors (S and L G > L A L A ), and externalizing behaviors predicted alcohol and marijuana problem severity at 6-month follow-up. Results indicated an indirect (p < 0.05) and non-specific (i.e., both alcohol and marijuana severity) effect of 5-HTTLPR genotype on youth substance use treatment outcomes, with externalizing behaviors as an important linking factor. Adolescents in substance use treatment with low expressing (S and L G ) 5-HTTLPR alleles and externalizing behavior might benefit from intervention that addresses serotonergic functioning, externalizing behaviors, and substance use to improve outcomes.
KW - Adolescent
KW - Alcohol
KW - Externalizing behavior
KW - Genetics
KW - Marijuana
KW - Serotonin transporter
UR - http://www.scopus.com/inward/record.url?scp=85061968176&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061968176&partnerID=8YFLogxK
U2 - 10.3389/fped.2014.00071
DO - 10.3389/fped.2014.00071
M3 - Article
AN - SCOPUS:85061968176
SN - 2296-2360
VL - 2
JO - Frontiers in Pediatrics
JF - Frontiers in Pediatrics
IS - JUL
M1 - 71
ER -